A Zhalilov, F Achilova
The prevalence of iron deficiency anemia in children at an early age according to WHO ranges from 17.5 to 30%. The causes of iron deficiency in children are quite diverse. Efficiency ferrotherapy is an inte-gral indicator of two components - the actual therapeutic effectiveness in relieving anemic syndrome and tolerability of a ferropreparation sick. The study involved 55 patients with grade 1-2 IDA children aged 1 to 3 years. The main group received iron (III) hydroxide polymaltose complex in grape juice (IHPCGJ) as monotherapy, the control group IHPC syrup, without the addition of juice. The effectiveness of IHPCGJ con-firmed what is already on the 15-20 day of treatment, there came a certain regression of clinical symptoms and positive changes in the system morfofunktsional eritrotsitary sick children. These results allow us to rec-ommend IHPCGJ, and bioavailability and bioassimilaty IHPCGJ significantly higher as a safe and effective phytopreparation for the treatment and prevention of iron deficiency anemia in children older than 1 year,
rather than iron supplementation with oral administration